CN114099571A - Composition for treating arthralgia and preparation method thereof - Google Patents
Composition for treating arthralgia and preparation method thereof Download PDFInfo
- Publication number
- CN114099571A CN114099571A CN202111486271.9A CN202111486271A CN114099571A CN 114099571 A CN114099571 A CN 114099571A CN 202111486271 A CN202111486271 A CN 202111486271A CN 114099571 A CN114099571 A CN 114099571A
- Authority
- CN
- China
- Prior art keywords
- parts
- composition
- treating
- treating arthralgia
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006820 Arthralgia Diseases 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 43
- 235000014101 wine Nutrition 0.000 claims abstract description 23
- 239000004863 Frankincense Substances 0.000 claims abstract description 20
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 19
- 241000258920 Chilopoda Species 0.000 claims abstract description 18
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 18
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 18
- 241000218671 Ephedra Species 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 17
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 17
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 17
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 16
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 16
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 16
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 16
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 16
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 16
- 241000239226 Scorpiones Species 0.000 claims abstract description 15
- 239000000052 vinegar Substances 0.000 claims abstract description 13
- 235000021419 vinegar Nutrition 0.000 claims abstract description 13
- 240000002924 Platycladus orientalis Species 0.000 claims abstract description 4
- 244000061520 Angelica archangelica Species 0.000 claims abstract 5
- 239000000047 product Substances 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 15
- 244000306301 Caesalpinia sappan Species 0.000 claims description 14
- 235000015162 Caesalpinia sappan Nutrition 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 241001106477 Paeoniaceae Species 0.000 claims description 9
- 241000131808 Scolopendra Species 0.000 claims description 9
- 238000000227 grinding Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 235000020097 white wine Nutrition 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 241000274177 Juniperus sabina Species 0.000 claims description 6
- 241000522620 Scorpio Species 0.000 claims description 6
- 239000009490 scorpio Substances 0.000 claims description 6
- 238000010411 cooking Methods 0.000 claims description 4
- 241000717739 Boswellia sacra Species 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 240000005308 Juniperus chinensis Species 0.000 claims description 2
- 244000184734 Pyrus japonica Species 0.000 claims description 2
- 241000736032 Sabia <angiosperm> Species 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 47
- 230000001737 promoting effect Effects 0.000 abstract description 28
- 208000002193 Pain Diseases 0.000 abstract description 27
- 230000036407 pain Effects 0.000 abstract description 27
- 210000004369 blood Anatomy 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 26
- 239000003814 drug Substances 0.000 abstract description 24
- 230000017531 blood circulation Effects 0.000 abstract description 18
- 210000004185 liver Anatomy 0.000 abstract description 13
- 230000001717 pathogenic effect Effects 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 235000019658 bitter taste Nutrition 0.000 abstract description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 3
- 239000006185 dispersion Substances 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000001050 lubricating effect Effects 0.000 abstract description 2
- 230000001954 sterilising effect Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 241000195974 Selaginella Species 0.000 abstract 1
- 230000037384 skin absorption Effects 0.000 abstract 1
- 231100000274 skin absorption Toxicity 0.000 abstract 1
- 230000008961 swelling Effects 0.000 description 19
- 206010042674 Swelling Diseases 0.000 description 17
- 230000006870 function Effects 0.000 description 13
- 241000125175 Angelica Species 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 208000005392 Spasm Diseases 0.000 description 9
- 230000009471 action Effects 0.000 description 9
- 241000736199 Paeonia Species 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 241001116742 Drynaria Species 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 241000721662 Juniperus Species 0.000 description 6
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000002795 scorpion venom Substances 0.000 description 6
- 210000002435 tendon Anatomy 0.000 description 6
- 201000000736 Amenorrhea Diseases 0.000 description 5
- 206010001928 Amenorrhoea Diseases 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 5
- 231100000540 amenorrhea Toxicity 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000001914 calming effect Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000002082 anti-convulsion Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- -1 dihydroflavonol glycoside Chemical class 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 244000000010 microbial pathogen Species 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 235000019633 pungent taste Nutrition 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 2
- 241000208229 Burseraceae Species 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241001481692 Mesobuthus martensii Species 0.000 description 2
- 208000019695 Migraine disease Diseases 0.000 description 2
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 241001480050 Trichophyton violaceum Species 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003556 anti-epileptic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 238000000554 physical therapy Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- LFJQCDVYDGGFCH-JTQLQIEISA-N (+)-β-phellandrene Chemical compound CC(C)[C@@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-JTQLQIEISA-N 0.000 description 1
- LFJQCDVYDGGFCH-SNVBAGLBSA-N (+/-)-beta-Phellandrene Natural products CC(C)[C@H]1CCC(=C)C=C1 LFJQCDVYDGGFCH-SNVBAGLBSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- QQUHMASGPODSIW-UHFFFAOYSA-N Albiflorin Natural products C=1C=CC=CC=1C(=O)OCC12C(=O)OC3(C)CC(O)C1CC32OC1OC(CO)C(O)C(O)C1O QQUHMASGPODSIW-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 206010006312 Breast swelling Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 241000239225 Buthidae Species 0.000 description 1
- 241000239311 Buthus Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 101000777488 Heteractis magnifica DELTA-stichotoxin-Hmg2b Proteins 0.000 description 1
- 101000588275 Heteractis magnifica Delta-stichotoxin-Rpa1b Proteins 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000784329 Juniperus formosana Species 0.000 description 1
- 244000162475 Juniperus rigida Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000229179 Ledebouriella Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010024796 Logorrhoea Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001480037 Microsporum Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 241001378686 Myricaria paniculata Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 101000783409 Naja anchietae Long neurotoxin 1 Proteins 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000431987 Neocheiropteris fortunei Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 101710138657 Neurotoxin Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 241000124464 Paeonia veitchii Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- 241001334235 Scolopendra mutilans Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 241001300193 Speranskia Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 241000893011 Tamaricaceae Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241000893963 Trichophyton concentricum Species 0.000 description 1
- 241000223229 Trichophyton rubrum Species 0.000 description 1
- 241001480046 Trichophyton schoenleinii Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- QQUHMASGPODSIW-ICECTASOSA-N albiflorin Chemical compound O([C@@]12C[C@H]3[C@H](O)C[C@@]1(OC(=O)[C@]32COC(=O)C=1C=CC=CC=1)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QQUHMASGPODSIW-ICECTASOSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003659 bee venom Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- LFJQCDVYDGGFCH-UHFFFAOYSA-N beta-phellandrene Natural products CC(C)C1CCC(=C)C=C1 LFJQCDVYDGGFCH-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- MLWIYODOURBGPI-MRXNPFEDSA-N brazilein Chemical compound C12=CC=C(O)C=C2OC[C@@]2(O)C1=C1C=C(O)C(=O)C=C1C2 MLWIYODOURBGPI-MRXNPFEDSA-N 0.000 description 1
- MLWIYODOURBGPI-UHFFFAOYSA-N brazilein Natural products C12=CC=C(O)C=C2OCC2(O)C1=C1C=C(O)C(=O)C=C1C2 MLWIYODOURBGPI-UHFFFAOYSA-N 0.000 description 1
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 description 1
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 description 1
- 201000003516 breast abscess Diseases 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000005240 left ventricle Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000009835 oxypaeoniflora Substances 0.000 description 1
- FCHVXNVDFYXLIL-QYDSDWLYSA-N oxypaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@@]1(C[C@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=C(O)C=C1 FCHVXNVDFYXLIL-QYDSDWLYSA-N 0.000 description 1
- RLXWQODPAWIVOI-UHFFFAOYSA-N oxypaeoniflorin Natural products OCC1OC(OC23CC4C5(O)CC2OC(O5)C34COC(=O)c6ccc(O)cc6)C(O)C(O)C1O RLXWQODPAWIVOI-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229930195126 picroside Natural products 0.000 description 1
- KEUKDVIGAVVGLF-RUYHYXBRSA-N picroside I Natural products OC[C@]12O[C@H]1[C@@H]3O[C@@H](O[C@@H]4O[C@H](COC(=O)C=Cc5ccccc5)[C@@H](O)[C@H](O)[C@H]4O)C=C[C@@H]3[C@H]2O KEUKDVIGAVVGLF-RUYHYXBRSA-N 0.000 description 1
- AKNILCMFRRDTEY-UHFFFAOYSA-N picroside II Natural products C1=C(O)C(OC)=CC(C(=O)OC2C3C(C(OC=C3)OC3C(C(O)C(O)C(CO)O3)O)C3(CO)OC32)=C1 AKNILCMFRRDTEY-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of Chinese herbal medicines, and discloses a composition for treating arthralgia and a preparation method thereof. The external application is suitable for treating arthralgia caused by rheumatoid arthritis, is beneficial to curing the arthralgia caused by conventional causes and relieving the symptoms of the arthralgia caused by rheumatoid arthritis. Bitter taste and warm nature; the liver meridian and kidney meridian entered are the therapeutic criteria. The Chinese medicinal composition has the effects of promoting blood circulation to remove blood stasis, dispelling pathogenic wind and relieving pain after being combined with garden balsam stem, rhizoma drynariae, angelica tail, red paeony root, frankincense, myrrh, sapanwood, divaricate saposhnikovia root, Chinese arborvitae twig, spikemoss twig, raw ephedra, scorpion and centipede. Decocting to separate out effective components, adding yellow wine and Chinese liquor, standing, sterilizing, and promoting skin absorption. After the product is sprayed, a drug film is formed on the skin surface of a patient, water, white vinegar and glycerol are added, the white vinegar is beneficial to the dispersion of the glycerol, the glycerol has a lubricating effect, the water is used for harmonizing the drugs and is used as a carrier for driving the drugs to be attached to the skin surface of the patient when the product is sprayed subsequently.
Description
Technical Field
The invention belongs to the technical field of Chinese herbal medicines, and particularly relates to a composition for treating arthralgia and a preparation method thereof.
Background
Rheumatic arthralgia refers to a disease with muscle and joint pain caused by wind-cold-dampness pathogen, which can not only cause the joint pain of various parts of waist and legs, which is very intolerable for patients, and difficulty in walking of lower limbs, but also can cause paralysis and lifelong disability. The incidence rate of rheumatic arthralgia in people is high and tends to rise year by year, and many people are unconscious and asymptomatic when suffering from the rheumatic arthralgia, but the symptoms of the rheumatic arthralgia are more and more severe with the age.
The traditional Chinese medicine considers that the etiology and the pathology of the rheumatic-cold arthralgia have two aspects: 1. physically weak pathogen invasion: the deficiency of the body, loose striae and skin striae, insecurity of ying and defensive qi, retention of exogenous pathogenic factors in meridians, joints and muscles, blockage of qi and blood, and unsmooth circulation; 2. affection of exogenous wind-cold-dampness pathogen: for those with irregular climate change, alternating cold and hot conditions, or damp residence, wading of water and rain, the exogenous pathogenic factors directly enter the muscles, joints, tendons and vessels to cause arthralgia syndrome.
At present, most of the medicines adopted by western medicine for treating the disease are antibiotics, hormones and analgesics, and the physiotherapy is heat treatment, physiotherapy, acupuncture and massage. The traditional Chinese medicine is used for treating patients with a long disease period, but the long-term taking of the medicine not only can generate drug resistance, but also can generate adverse reactions such as gastrointestinal function damage, osteoporosis, endocrine disturbance, nervous system disorder, cortin hyperfunction and the like, and can not completely remove roots, and the traditional Chinese medicine is used for long-term persistence, can not be interrupted and can not be cured radically.
Disclosure of Invention
In order to solve the technical problems of poor administration effect and unsatisfactory treatment result of the joint pain caused by the rheumatoid arthritis in the prior art, the invention aims to provide a composition for treating the joint pain and a preparation method thereof.
The technical scheme adopted by the invention is as follows: the composition for treating arthralgia is mainly prepared from the following raw materials in parts by mass:
10-50 parts of garden balsam stem, 10-50 parts of rhizoma drynariae, 6-30 parts of angelica tail, 6-30 parts of red paeony root, 3-15 parts of frankincense, 3-15 parts of myrrh, 3-15 parts of sappan wood, 3-15 parts of divaricate saposhnikovia root, 10-50 parts of cacumen biotae twig, 10-50 parts of sabina chinensis, 6-30 parts of raw ephedra, 1-10 parts of scorpion and 1-10 parts of centipede.
Garden balsam stem, name of traditional Chinese medicine. Is whole plant of Speranskia turbinata (Bunge) Baill. The plant radix seu folium Broussonetiae is distributed in Liaoning, Jilin, inner Mongolia, Hebei, Henan, Shanxi, Gansu, Shandong, Jiangsu, Anhui, and Sichuan of China. Has the effects of dispelling pathogenic wind, removing dampness, relaxing muscles and tendons, promoting blood circulation, removing blood stasis, relieving swelling, removing toxic substance, and relieving pain. It can be used for treating rheumatic arthralgia, contracture of tendons and bones, cold-dampness, tinea pedis, lumbar sprain, paralysis, amenorrhea, eczema of scrotum, skin ulcer, furuncle, and pyogenic infections. Pungent flavor and warm nature. Enter liver and kidney meridians.
Drynaria rhizome, the name of traditional Chinese medicine. Is rhizome of Drynaria fortunei (Kunze) J.Sm. of Drynaria of Drynariaceae. Has effects of promoting blood circulation, promoting wound healing, invigorating kidney, and strengthening bone. Can be used for treating traumatic injury or wound, bone and muscle injury, blood stasis, swelling and pain, lumbago, asthenia, tinnitus, deafness, toothache, and chronic diarrhea. Bitter taste and warm nature; it enters liver and kidney meridians. Chemical components: contains naringin, rhizoma Drynariae dihydroflavonol glycoside, and garrulous bone acid supplementing agent. The pharmacological action is as follows: the water decoction and alcohol precipitation solution has effects of preventing increase of serum cholesterol and triglyceride, and preventing formation of atherosclerotic plaque; rhizoma Drynariae polysaccharide and rhizoma Drynariae dihydroflavoneglycoside have effects of reducing blood lipid and resisting arteriosclerosis. The bone fragment can promote the absorption of calcium by bones, improve the levels of blood calcium and blood phosphorus and facilitate the healing of fracture; improve cartilage cells and delay the degenerative change of bone cells. In addition, the rhizoma drynariae dihydroflavonol glycoside has obvious sedative and analgesic effects.
The surface of the angelica root, i.e. the tail of Dang Gui, is yellowish-brown to tan, with longitudinal wrinkles and transverse long skin pores. The root and head (return to the head) has a diameter of 1.5-4 cm, has ring veins, has a round and blunt upper end, and can activate blood circulation to remove blood stasis, and treat amenorrhea and blood stasis accumulation and swelling pain.
Red peony root, name of Chinese traditional medicine. Is dried root of Paeonia lactiflora pall or Paeonia veitchii Lynch of Paeonia of Paeoniaceae. Has the effects of clearing heat, cooling blood, promoting blood circulation and removing blood stasis. It can be used for treating macula due to toxic heat, hematemesis, epistaxis, conjunctival congestion, swelling and pain, carbuncle, swelling, sore, ulcer, stagnation of liver-qi, hypochondriac pain, amenorrhea, dysmenorrhea, abdominal mass, abdominal pain, and traumatic injury. Bitter taste and slightly cold nature; it enters liver meridian. Chemical components: the product contains paeoniflorin, albiflorin, oxypaeoniflorin, benzoylpaeoniflorin, peonidine, peoniflorin, gallotannin, benzoic acid, volatile oil, fatty oil, resin, etc. The pharmacological action is as follows: the product has effects in dilating coronary artery and increasing coronary blood flow; the water extract of radix Paeoniae Rubra, paeoniflorin, radix Paeoniae Rubra and its derivatives have platelet aggregation inhibiting effect; the water decoction can prolong the time of in vitro thrombosis and reduce the dry weight of the thrombus. The paeoniflorin has tranquilizing, antiinflammatory and analgesic effects. Radix Paeoniae fluid extract and paeoniflorin have anticonvulsive effect. Radix Paeoniae Rubra and paeoniflorin have spasmolytic effect; the red peony root has obvious enhancement effect on the synthesis of hepatocyte DNA and stronger inhibition effect on various pathogenic microorganisms.
Frankincense, name of traditional Chinese medicine. Is resin exuded from bark of Boswellia carterii Birdw of Boswellia of Burseraceae and plants of the same genus. Has effects of promoting blood circulation, activating qi-flowing, relieving pain, eliminating swelling and promoting granulation. The traditional Chinese medicine is mainly used for activating blood and promoting qi circulation to relieve pain, reducing swelling and promoting granulation, and relieving pain due to qi stagnation and blood stasis. Pungent and bitter taste, warm nature; it enters heart, liver and spleen meridians. Chemical components: mainly contains resin, gum and volatile oil. The main components of the resin are free alpha, beta-boswellic acid, combined boswellic acid and boswellic resin hydrocarbon; the gum comprises calcium and magnesium salt of arabonic acid, and tragacanth as main ingredient; the volatile oil contains pinene, alpha-phellandrene, beta-phellandrene, etc. The pharmacological action is as follows: olibanum has effects of relieving pain, diminishing inflammation, increasing leukocyte, accelerating excretion of inflammatory exudation, and promoting wound healing; pinene contained in the extract has the effect of eliminating phlegm; the frankincense can obviously relieve gastric mucosa injury and stress mucosa injury caused by aspirin, phenylbutazone and reserpine, and reduce pyloric ligation ulcer index and gastric juice free acidity.
Myrrh, name of traditional Chinese medicine. Is oleoresin exuded from bark of Commiphora myrrha Engl. or other plants of the same genus of Commiphora of Burseraceae. Has effects of promoting blood circulation, relieving pain, eliminating swelling, and promoting granulation. Can be used for treating traumatic injury, swelling and pain due to blood stasis, carbuncle, cellulitis, swelling and pain, unhealed skin ulcer, chest pain, hypochondriac pain, cardialgia, dysmenorrhea, puerperal abdominal pain, rheumatalgia, and abdominal mass. Pungent, bitter and neutral in flavor; it enters heart, liver and spleen meridians. Chemical components: comprises Myrrha resin, volatile oil (eugenol, etc.), gum, small amount of bitter substances, and also comprises bisabolol, formic acid, acetic acid, oxidase, etc. The pharmacological action is as follows: 1. effects on the metabolic system: has effects in reducing blood lipid and preventing formation of atherosclerotic plaque. 2. Effects on uterus: the myrrh firstly shows transient excitation to the isolated uterus, so that the uterine tension is improved, the contraction frequency is increased, and then the inhibition phenomenon is shown. 3. The function of resisting pathogenic microorganisms: the water-soaking agent has inhibitory effect on various pathogenic fungi such as Trichophyton violaceum, Trichophyton concentricum, Trichophyton schoenleini, etc., and the volatile oil can slightly inhibit mould. 4. In addition, Mo Yao has local stimulation and can stimulate the peristalsis of intestine.
Lignum sappan, name of Chinese traditional medicine. Is dried heartwood of Caesalpinia sappan L. of Rutaceae of Leguminosae. Has effects of promoting blood circulation, healing wound, removing blood stasis, and dredging channels. Can be used for treating traumatic injury, fracture, injury of tendons and bones, blood stasis, swelling and pain, amenorrhea due to blood stasis, puerperal abdominal pain due to blood stasis, dysmenorrhea, pain of heart and abdomen, carbuncle, swelling, and sore. Sweet, salty, pungent and neutral in nature; it enters heart and liver meridians. Chemical components: contains brazilein, volatile oil (mainly phellandrene and ocimene) and tannin. The pharmacological action is as follows: 1. influence on the circulation system: the lignum sappan decoction can enhance the contraction of in vitro frog heart, and the water decoction can increase coronary blood flow and promote microcirculation. 2. Effects on the blood system: brazilin and hematoxylin can inhibit platelet aggregation induced by ADP and promote blood coagulation. 3. Effects on the nervous system: the lignum sappan decoction has sedative and hypnotic effects, and can resist central excitation of strychnine and cocaine. 4. The function of resisting pathogenic microorganisms: the lignum sappan decoction and decoction have effect in inhibiting Bacillus leukotrichiae, Staphylococcus aureus, and Salmonella typhi. 5. In addition, lignum sappan has anticancer, antiinflammatory, and immunosuppressive effects.
Ledebouriella root, name of Chinese medicine. Is root of Saposhnikovia divaricata (Turcz.) Schischk. of Saposhnikovia of Umbelliferae. Has the effects of dispelling pathogenic wind, relieving exterior syndrome, eliminating dampness, relieving pain, and relieving spasm. It can be used for treating exterior syndrome due to exogenous pathogenic factors, rubella pruritus, rheumatalgia, and tetanus. Pungent and sweet in flavor and slightly warm in nature; it enters bladder and liver meridians. Chemical components: the product contains volatile oil, mannitol, beta-sitosterol, picroside, phenols, polysaccharides, organic acids, etc. The pharmacological action is as follows: the product has antipyretic, antiinflammatory, tranquilizing, analgesic, anticonvulsive, and antiallergic effects. The divaricate saposhnikovia root fresh juice has a certain antibacterial effect on pseudomonas aeruginosa and staphylococcus aureus, the decoction has different degrees of inhibition effects on dysentery bacillus, hemolytic streptococcus and the like, and the decoction has the effect of enhancing the phagocytic function of abdominal cavity macrophages of mice.
Cacumen biotae, named as traditional Chinese medicine. Is the tender branch of the Chinese arborvitae twig of Myricaria paniculata P.Y.Zhang et Y.J.Zhang of Tamaricaceae. Has the effects of relieving exterior syndrome, promoting eruption, dispelling pathogenic wind and relieving itching. Can be used for treating measles, fever, cough, rheumatalgia, rubella, pruritus, and tinea. Pungent and sweet in flavor and warm in nature; it enters lung and liver meridians.
Sabina vulgaris, name of Chinese medicine. Is root, root bark or branch and leaf of Juniperus formosana Hayata of Juniperus of Cupressaceae. The plant Juniperus Rigida is distributed in southwest, Shaanxi, Gansu, Qinghai, Jiangsu, Anhui, Zhejiang, Fujian, Taiwan, Jiangxi, Hubei, Hunan, Tibet and other places in China. Has the effects of clearing away heat and toxic materials, eliminating dampness and relieving itching. It can be used for treating measles, hyperpyrexia, eczema, tinea, and sore. Bitter taste and cold nature. Enter liver meridian.
Raw Ma Huang is pungent and warm in nature and flavor. Has effects of inducing sweat, relieving exterior syndrome, dispersing lung qi, relieving asthma, and inducing diuresis to alleviate edema. Can be used for treating headache, nasal obstruction, rhinorrhea, sneeze, etc. caused by common cold due to wind-cold. In addition, the ephedra herb has the functions of ventilating the lung and relieving asthma, and can be used for treating cough, asthma and other diseases caused by wind-cold restraining the lung. According to clinical pharmacology, the ephedra has the functions of strengthening heart, promoting urination and expanding blood vessels, and can relieve contracted bronchus, so that the ephedra can be used for treating diseases such as chronic bronchitis, bronchopneumonia, pulmonary heart disease, emphysema and the like.
Scorpio, named as Chinese medicine. Is dried body of Buthus martensii Karsch belonging to Buthus of Buthidae. Has effects of calming endogenous wind, relieving spasm, removing toxic substances, resolving hard mass, dredging collaterals, and relieving pain. Can be used for treating convulsion, spasm and convulsion due to various reasons; sores and ulcers, swelling, scrofula, tuberculosis, gangrene, breast abscess and swelling; stubborn arthralgia due to wind-damp evils, spasm of tendons and vessels; intractable migraine; and can be used for treating various tumors. Pungent taste and mild nature; it enters liver meridian. Chemical components: the product contains scorpion venom, a protein similar to snake venom neurotoxin. And comprises trimethylamine, betaine, taurine, palmitic acid, cholesterol, lecithin, ammonium salt and the like. And trace elements such as sodium, potassium, calcium, magnesium, iron, copper, zinc, manganese and the like. Most researches are carried out on scorpion toxin III and antiepileptic peptide (AEP) with the strongest analgesic activity. The pharmacological action is as follows: 1. action on the central nervous system: has analgesic, anticonvulsive, and antiepileptic effects. 2. Effect on the cardiovascular system: the scorpion venom of Buthus martensii Karsch has the effects of enhancing myocardial contractility and remarkably improving the contraction function of the left ventricle. Scorpion venom can raise blood pressure obviously. The compound scorpion oral liquid has the functions of resisting thrombosis, reducing the adhesion rate of blood platelets and delaying blood coagulation for healthy rabbits. 3. Immunological activity: the scorpion venom contains protein as main component and thus has certain antigenicity. 4. Other functions are as follows: scorpion venom can promote the release of acetylcholine, increase the levels of adrenaline and noradrenaline in blood plasma, affect the permeability of nerve membranes, and produce uterine contractions, resulting in early abortion. Also has antibacterial and antitumor effects.
Centipede, name of traditional Chinese medicine. Is dried product of Scolopendra subspinipes mutilans L.Koch of Scolopendra family. Has effects of calming endogenous wind, relieving spasm, removing toxic substances, resolving hard mass, dredging collaterals, and relieving pain. Mainly treats spasm and convulsion caused by various reasons; sores and ulcers, swelling, scrofula and tuberculosis; stubborn rheumatism and arthralgia; intractable migraine; bite by poisonous snake. Pungent taste and warm nature; it enters liver meridian. Chemical components: the product contains two components similar to bee venom, namely histamine-like substance and hemolytic protein. Contains fatty oil, cholesterol, formic acid, histidine, arginine, leucine, and other amino acids. It also contains saccharide, protein, and multiple trace elements such as Fe, Zn, Mn, Ca, Mg, etc. The pharmacological action is as follows: 1. effect on the cardiovascular system: the centipede water-soluble deproteinized extracting solution has the function of strengthening myocardial contraction force within a certain dosage range, and the myocardial contraction force is weakened by a large dosage. And has effects in lowering blood pressure and dilating blood vessel. 2. Anticonvulsant action: scolopendra and Scorpio have antagonistic effect on mice convulsion caused by half amount of convulsion of strychnine, Kadizao, and pure nicotine, and Scolopendra has stronger effect than Scorpio. 3. Impact on immune function: the Scolopendra granule has immunity enhancing effect. The high and low dose groups have the function of improving phagocytic ability of macrophages in abdominal cavities of mice. The centipede with proper amount has the function of inhibiting the humoral immunity function of mice when orally taken. 4. Anti-inflammatory action: centipede has a strong inhibition effect on acute and chronic inflammation. 5. Antifungal action: the Scolopendra soaking agent (1: 4) has effect in inhibiting dermatophytes such as Trichophyton violaceum, Trichophyton schoenleinii, Microsporum donovani, Epidermophyton grometns, Epidermophyton rubrum, and Trichophyton coloratum in test tube. 6. In addition, Scolopendra has analgesic and antitumor effects.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
20-40 parts of garden balsam stem, 20-40 parts of rhizoma drynariae, 12-24 parts of angelica tail, 12-24 parts of red paeony root, 6-12 parts of frankincense, 6-12 parts of myrrh, 6-12 parts of sappan wood, 6-12 parts of divaricate saposhnikovia root, 20-40 parts of cacumen biotae twig, 20-40 parts of sabia amurensis, 12-24 parts of raw ephedra, 4-8 parts of scorpion and 4-8 parts of centipede.
Preferably, the composition is mainly prepared from the following raw materials in parts by mass:
30 parts of garden balsam stem, 30 parts of rhizoma drynariae, 20 parts of angelica tail, 20 parts of red paeony root, 10 parts of frankincense, 10 parts of myrrh, 10 parts of sappan wood, 10 parts of divaricate saposhnikovia root, 30 parts of cacumen biotae, 30 parts of sabina japonica, 20 parts of raw ephedra, 6 parts of scorpion and 6 parts of centipede.
A method for preparing a composition for treating joint pain, the method comprising the steps of:
s1, selecting herba speranskiae tuberculatae, rhizoma Drynariae, radix Angelicae sinensis, radix Paeoniae Rubra, Olibanum, Myrrha, lignum sappan, radix Saposhnikoviae, cacumen Myricariae Germanicae, cortex et radix junci, herba Ephedrae, Scorpio and Scolopendra according to corresponding proportion, mixing, decocting, adding medicated wine after decocting, stirring, standing, filtering to obtain filtrate;
s2, drying and grinding the filtrate, adding water, white vinegar and glycerol, and mixing uniformly to obtain the finished product.
Preferably, in the step S1, the cooking temperature is 80-100 ℃.
Preferably, in the step S1, the cooking time is 2-3 hours.
Preferably, in step S1, the wine agent includes a mixture of yellow wine and white wine;
the volume ratio of the yellow wine to the white spirit is as follows: 2-3: 1;
the ratio of the volume of the medicated wine to the total mass of the garden balsam stem, the rhizoma drynariae, the angelica tail, the red paeony root, the frankincense, the myrrh, the sappan wood, the divaricate saposhnikovia root, the Chinese arborvitae twig, the sabina vulgaris, the raw ephedra, the scorpion and the centipede is as follows: 30-80 mL: 1.
preferably, in the step S1, the standing time is 1-2 hours.
Preferably, in the step S2, the particle size of the powder obtained after grinding is 10 to 50 nm.
Preferably, in step S2, the ratio of the weight of the ground powder, the volume of water, the volume of white vinegar and the volume of glycerin is: 10-20 g: 30-40 mL: 5-15mL and 10-20 mL.
The invention has the beneficial effects that:
the composition is applied in an external application mode, and the spray is suitable for treating the arthralgia caused by the rheumatoid arthritis, is beneficial to curing the arthralgia caused by the conventional causes, and is beneficial to relieving symptoms such as the arthralgia caused by the rheumatoid arthritis.
The composition provided by the invention is bitter in taste and warm in nature; the liver meridian and kidney meridian entered are the therapeutic criteria. Wherein, the garden balsam stem has the efficacies of dispelling wind and eliminating dampness, relaxing muscles and tendons and promoting blood circulation, eliminating stasis and swelling, and detoxifying and relieving pain; rhizoma Drynariae has effects of promoting blood circulation, tonifying kidney, and strengthening bone; the angelica tail can promote blood circulation to remove blood stasis, and treat the diseases of amenorrhea and blood stasis and swelling and pain; radix Paeoniae Rubra has effects of clearing heat, cooling blood, promoting blood circulation and removing blood stasis; the frankincense has the effects of activating blood circulation, promoting qi circulation, relieving pain, reducing swelling and promoting tissue regeneration; myrrh with the functions of promoting blood circulation, relieving pain, eliminating swelling and promoting granulation; lignum sappan with effects of promoting blood circulation, healing wound, removing blood stasis, and dredging channels; radix Saposhnikoviae has effects of dispelling pathogenic wind, relieving exterior syndrome, eliminating dampness, relieving pain, and relieving spasm; cacumen biotae branches and twigs have the effects of relieving exterior syndrome, promoting eruption, dispelling wind and arresting itching; the sabina vulgaris has the effects of clearing away heat and toxic materials, eliminating dampness and relieving itching; raw ephedra has the efficacies of sweating, relieving exterior syndrome, freeing lung, relieving asthma, inducing diuresis and reducing edema; scorpio has effects of calming endogenous wind, relieving spasm, removing toxic substances, resolving hard mass, dredging collaterals, and relieving pain; scolopendra has effects of calming endogenous wind, relieving spasm, counteracting toxic substances, resolving hard mass, dredging collaterals, and relieving pain.
The formula (III) has the effects of promoting blood circulation to remove blood stasis, dispelling wind and relieving pain after the raw materials are compatible, and achieves the purpose of treating arthralgia.
The preparation method of the formula comprises the steps of firstly separating out the active ingredients of the raw materials by boiling, then adding the yellow wine and the white wine and standing, and is used for further promoting the mixing of the active ingredients of the raw materials and the wine agent, providing the effects of disinfection and sterilization for subsequent use and promoting the absorption rate of skin. After the product is sprayed, in order to form a drug film on the skin surface of a patient, water, white vinegar and glycerol are added after the liquid is dried and ground, the white vinegar is beneficial to the dispersion of the glycerol, the glycerol has a lubricating effect, the water is used for harmonizing the drugs and is used as a carrier for driving the drugs to be attached to the skin surface of the patient during subsequent spraying.
Detailed Description
The present invention is further illustrated below with reference to specific examples. It will be appreciated by those skilled in the art that the following examples, which are set forth to illustrate the present invention, are intended to be part of the present invention, but not to be construed as limiting the scope of the present invention. The reagents used are all conventional products which are commercially available.
Example 1:
a method for preparing a composition for treating joint pain, comprising the steps of:
s1, selecting 100 g of garden balsam stem, 100 g of drynaria rhizome, 60 g of angelica tail, 60 g of red peony root, 30 g of frankincense, 30 g of myrrh, 30 g of sappan wood, 30 g of divaricate saposhnikovia root, 100 g of cacumen biotae, 100 g of juniper, 60 g of raw ephedra, 10 g of scorpion and 10 g of centipede according to a corresponding proportion, mixing, decocting at 80 ℃ for 2 hours, adding a wine agent (yellow wine: white wine: 2:1, V/V) after the decoction is finished, stirring uniformly, standing for 1 hour, and filtering to obtain a filtrate;
s2, drying and grinding the filtrate to obtain powder with a particle size of 10nm, and adding water, white vinegar and glycerol to mix uniformly to obtain the finished product.
Example 2:
a method for preparing a composition for treating joint pain, comprising the steps of:
s1, selecting 500 g of garden balsam stem, 500 g of drynaria rhizome, 300 g of angelica tail, 300 g of red peony root, 150 g of frankincense, 150 g of myrrh, 150 g of sappan wood, 150 g of divaricate saposhnikovia root, 500 g of cacumen biotae, 500 g of juniper, 300 g of raw ephedra, 100 g of scorpion and 100 g of centipede according to a corresponding proportion, mixing, decocting at 100 ℃ for 3 hours, adding a wine agent (yellow wine: white wine: 2:1, V/V) after the decoction is finished, stirring uniformly, standing for 2 hours, filtering, and obtaining a filtrate;
s2, drying and grinding the filtrate to obtain powder with a particle size of 50nm, and adding water, white vinegar and glycerol to mix uniformly to obtain the finished product.
Example 3:
a method for preparing a composition for treating joint pain, comprising the steps of:
s1, selecting 200 g of garden balsam stem, 200 g of drynaria rhizome, 120 g of angelica tail, 120 g of red peony root, 60 g of frankincense, 60 g of myrrh, 60 g of sappan wood, 60 g of divaricate saposhnikovia root, 200 g of cacumen biotae, 200 g of juniper, 120 g of raw ephedra, 40 g of scorpion and 40 g of centipede according to a corresponding proportion, mixing, decocting at 80 ℃ for 3 hours, adding a wine agent (yellow wine: white wine ═ 3:1, V/V) after the decoction is finished, stirring uniformly, standing for 1 hour, and filtering to obtain a filtrate;
s2, drying and grinding the filtrate to obtain powder with a particle size of 10nm, and adding water, white vinegar and glycerol to mix uniformly to obtain the finished product.
Example 4:
a method for preparing a composition for treating joint pain, comprising the steps of:
s1, selecting 400 g of garden balsam stem, 400 g of drynaria rhizome, 240 g of angelica tail, 240 g of red peony root, 120 g of frankincense, 120 g of myrrh, 120 g of sappan wood, 120 g of divaricate saposhnikovia root, 400 g of cacumen biotae, 400 g of juniper, 240 g of raw ephedra, 80 g of scorpion and 80 g of centipede according to a corresponding proportion, mixing, decocting at 100 ℃ for 2 hours, adding a wine agent (yellow wine: white wine ═ 3:1, V/V) after the decoction is finished, stirring uniformly, standing for 2 hours, and filtering to obtain a filtrate;
s2, drying and grinding the filtrate to obtain powder with a particle size of 50nm, and adding water, white vinegar and glycerol to mix uniformly to obtain the finished product.
Example 5:
a method for preparing a composition for treating joint pain, comprising the steps of:
s1, selecting 300 g of garden balsam stem, 300 g of drynaria rhizome, 200 g of angelica tail, 200 g of red peony root, 100 g of frankincense, 100 g of myrrh, 100 g of sappan wood, 100 g of divaricate saposhnikovia root, 300 g of cacumen biotae, 300 g of juniper, 200 g of raw ephedra, 60 g of scorpion and 60 g of centipede according to a corresponding proportion, mixing, decocting at 100 ℃ for 2 hours, adding a wine agent (yellow wine: white wine: 2:1, V/V) after the decoction is finished, stirring uniformly, standing for 1 hour, filtering, and obtaining a filtrate;
s2, drying and grinding the filtrate to obtain powder with a particle size of 50nm, and adding water, white vinegar and glycerol to mix uniformly to obtain the finished product.
The using method comprises the following steps: a spray for external use. 3-5 times per day, and in the first and second treatment courses, spraying at 6-hour intervals; the third course of treatment begins, spraying once every 12 hours. Each treatment period was 7 days.
The present invention is not limited to the above alternative embodiments, and any other products in various forms can be obtained by the present invention, and the present invention is within the protection scope of the present invention. The above embodiments should not be construed as limiting the scope of the present invention, and it will be understood by those skilled in the art that modifications may be made to the technical solutions described in the above embodiments, or equivalent substitutions may be made to some or all of the technical features thereof, without departing from the scope of the present invention, and at the same time, such modifications or substitutions may not make the essence of the corresponding technical solutions depart from the scope of the embodiments of the present invention.
Claims (10)
1. The composition for treating arthralgia is characterized by being prepared from the following raw materials in parts by mass:
10-50 parts of garden balsam stem, 10-50 parts of rhizoma drynariae, 6-30 parts of angelica tail, 6-30 parts of red paeony root, 3-15 parts of frankincense, 3-15 parts of myrrh, 3-15 parts of sappan wood, 3-15 parts of divaricate saposhnikovia root, 10-50 parts of cacumen biotae twig, 10-50 parts of sabina chinensis, 6-30 parts of raw ephedra, 1-10 parts of scorpion and 1-10 parts of centipede.
2. The composition for treating arthralgia according to claim 1, wherein the composition is prepared from the following raw materials in parts by mass:
20-40 parts of garden balsam stem, 20-40 parts of rhizoma drynariae, 12-24 parts of angelica tail, 12-24 parts of red paeony root, 6-12 parts of frankincense, 6-12 parts of myrrh, 6-12 parts of sappan wood, 6-12 parts of divaricate saposhnikovia root, 20-40 parts of cacumen biotae twig, 20-40 parts of sabia amurensis, 12-24 parts of raw ephedra, 4-8 parts of scorpion and 4-8 parts of centipede.
3. The composition for treating arthralgia according to claim 2, wherein the composition is prepared from the following raw materials in parts by mass:
30 parts of garden balsam stem, 30 parts of rhizoma drynariae, 20 parts of angelica tail, 20 parts of red paeony root, 10 parts of frankincense, 10 parts of myrrh, 10 parts of sappan wood, 10 parts of divaricate saposhnikovia root, 30 parts of cacumen biotae, 30 parts of sabina japonica, 20 parts of raw ephedra, 6 parts of scorpion and 6 parts of centipede.
4. A method for preparing a composition for treating joint pain according to any one of claims 1 to 3, comprising the steps of:
s1, selecting herba speranskiae tuberculatae, rhizoma Drynariae, radix Angelicae sinensis, radix Paeoniae Rubra, Olibanum, Myrrha, lignum sappan, radix Saposhnikoviae, cacumen Myricariae Germanicae, cortex et radix junci, herba Ephedrae, Scorpio and Scolopendra according to corresponding proportion, mixing, decocting, adding medicated wine after decocting, stirring, standing, filtering to obtain filtrate;
s2, drying and grinding the filtrate, adding water, white vinegar and glycerol, and mixing uniformly to obtain the finished product.
5. The method for preparing a composition for treating arthralgia according to claim 4, wherein the cooking temperature in step S1 is 80-100 ℃.
6. The method for preparing a composition for treating arthralgia according to claim 5, wherein the cooking time of step S1 is 2-3 hours.
7. The method for preparing a composition for treating arthralgia according to claim 4, wherein in said step S1, the wine comprises a mixture of yellow wine and white wine;
the volume ratio of the yellow wine to the white spirit is as follows: 2-3: 1;
the ratio of the volume of the medicated wine to the total mass of the garden balsam stem, the rhizoma drynariae, the angelica tail, the red paeony root, the frankincense, the myrrh, the sappan wood, the divaricate saposhnikovia root, the Chinese arborvitae twig, the sabina vulgaris, the raw ephedra, the scorpion and the centipede is as follows: 30-80 mL: 1.
8. the method for preparing a composition for treating arthralgia according to claim 4, wherein said step S1 is performed by standing for 1-2 hours.
9. The method for preparing a composition for treating arthralgia according to claim 4, wherein the powder obtained after grinding in step S2 has a particle size of 10-50 nm.
10. The method for preparing a composition for treating arthralgia according to claim 4, wherein the ratio of the weight of the ground powder, the volume of water, the volume of white vinegar, and the volume of glycerin in step S2 is: 10-20 g: 30-40 mL: 5-15mL and 10-20 mL.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111486271.9A CN114099571A (en) | 2021-12-07 | 2021-12-07 | Composition for treating arthralgia and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111486271.9A CN114099571A (en) | 2021-12-07 | 2021-12-07 | Composition for treating arthralgia and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114099571A true CN114099571A (en) | 2022-03-01 |
Family
ID=80367337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111486271.9A Pending CN114099571A (en) | 2021-12-07 | 2021-12-07 | Composition for treating arthralgia and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114099571A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101352503A (en) * | 2008-08-27 | 2009-01-28 | 杨振才 | Plaster for treating joint ache and preparation method thereof |
CN103393897A (en) * | 2013-07-22 | 2013-11-20 | 陈汪 | Externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia and preparation method thereof |
-
2021
- 2021-12-07 CN CN202111486271.9A patent/CN114099571A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101352503A (en) * | 2008-08-27 | 2009-01-28 | 杨振才 | Plaster for treating joint ache and preparation method thereof |
CN103393897A (en) * | 2013-07-22 | 2013-11-20 | 陈汪 | Externally used traditional Chinese medicine for treating hyperostosis and rheumatic ostealgia and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105412893A (en) | Jingutong spray and making method thereof | |
CN102258746B (en) | Ointment for treating surface of burns and scalds | |
CN105250940A (en) | Traditional Chinese medicinal plaster for treating stomachache diseases, and preparation method thereof | |
CN106266885A (en) | A kind of clinical laboratory Traditional Chinese medicine disinfectant | |
CN103611133A (en) | Blood circulation promotion and pain alleviation gel and preparation method thereof | |
CN103100016B (en) | Chinese medicament for treating pruritus cutanea | |
CN108853277A (en) | A kind of Traditional Chinese medicine disinfectant for acupuncture | |
CN114099571A (en) | Composition for treating arthralgia and preparation method thereof | |
CN110384785B (en) | A topical Chinese medicinal liquid for treating viral common cold, and its preparation method | |
CN106421283A (en) | Traditional Chinese medicine ointment for treating skin diseases | |
CN113181318A (en) | Traditional Chinese medicine ointment for treating haemorrhoids and preparation method thereof | |
CN106177639A (en) | One treats psoriatic Chinese medicine composition and preparation method thereof | |
CN112691157A (en) | Formula and preparation method of medicinal material composition for treating rheumatic arthritis | |
CN105412596A (en) | Traditional Chinese medicine composition for treating liver tumors and preparation method thereof | |
CN110772623A (en) | Traditional Chinese medicine for treating prostate | |
CN104524118A (en) | Itching-relieving soothing cream and preparation method thereof | |
CN103816399A (en) | Traditional Chinese medicinal preparation for treating canine distemper | |
CN104083516A (en) | Traditional Chinese medicinal composition for treating eczema | |
CN112402508A (en) | Traditional Chinese medicine composition for treating herpes zoster and preparation method thereof | |
CN111084842B (en) | External traditional Chinese medicine composition for treating scapulohumeral periarthritis, cervical spondylosis, lumbar disc herniation and osteoarthritis | |
CN110721302A (en) | Anti-inflammatory analgesic composition and application thereof | |
CN105878655B (en) | Jinqianlitong granules for treating cholelithiasis | |
CN106038904B (en) | Lysimachia christinae and cholangiopsis cochinchinensis granule composition and preparation method thereof | |
CN104644933B (en) | Relaxing tendons and activating collaterals pain-relieving Babu cream and preparation method thereof | |
CN105327053A (en) | Pharmaceutical for treating mammary lump with liver qi depression and phlegm stasis syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220301 |
|
RJ01 | Rejection of invention patent application after publication |